ZZ Biotech has been developing 3K3A-APC, a genetically engineered variant of human activated protein C (APC), a serine protease, that has been optimized for human therapeutic use. The company is pleased to announce it has agreed in principle to license its 3K3A-APC program in dermatology to Dermatherix, Pty Ltd. Dermatherix is a pioneering biotech company dedicated to advancing wound therapies through innovative research. ZZ Biotech is excited to see its drug 3K3A-APC advanced by the team at Dermatherix.
| Website | http://zzbiotech.com/ |
| Employees | 14 (0 on RocketReach) |
| Founded | 2006 |
| Phone | +1 619-574-0820 |
| Industry | Pharmaceutical Manufacturing, Drug Discovery, Biotechnology |
Looking for a particular ZZ Biotech employee's phone or email?